Technology News and Research

RSS

FDA approves Globus Medical’s SECURE-C Cervical Artificial Disc

Globus Medical, Inc., today announced that the Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for the SECURE-C Cervical Artificial Disc. Clinical data from a 380 patient investigational device exemption (IDE) study demonstrate that SECURE-C is statistically superior to anterior cervical discectomy and fusion (ACDF) in terms of overall success, subsequent surgery at the index level, device-related adverse events, and patient satisfaction at 24 months.

29 Sep 2012

Autism Speaks announces new round of research grants

Autism Speaks, the world's leading autism science and advocacy organization, today announced the awarding of new research grants totaling nearly $5 million. "Autism Speaks is committed to continuing our research which has tremendous potential to increase our understanding of autism and addressing the needs of individuals with autism," said Autism Speaks Co-founder Bob Wright, "and we are grateful to the donors who make this research possible."

29 Sep 2012

BioTime forms new wholly owned subsidiary

BioTime, Inc., an Alameda-based company engaged in research and development of innovative new products in the field of regenerative medicine utilizing stem cells and related technology, announced today that it has formed a new wholly owned subsidiary, BioTime Acquisition Corporation, to pursue opportunities and acquire assets and businesses in the fields of stem cells and regenerative medicine.

29 Sep 2012

The Genealogy Event to discuss scientific breakthroughs in human genomic study

Scientific breakthroughs in the study of the human genome coupled with online access to massive genealogical records have opened the doors of ancestral investigation to include all those interested in unearthing their roots and, on October 26-27 at the Metropolitan Pavilion in New York City, The Genealogy Event will feature exciting learning opportunities and resources for both novice and professional enthusiasts.

28 Sep 2012

The state of science and technology in Canada, 2012

An authoritative, evidence-based assessment of the state of science and technology in Canada has found that Canadian science and technology is healthy, growing and internationally respected. Over the past five years, real improvements have occurred in the magnitude and quality of Canadian science and technology.

28 Sep 2012

Hip arthroscopy system launched by DePuy Mitek

DePuy Mitek, Inc., a leading developer and manufacturer of orthopaedic sports medicine products and soft tissue repair devices, announced the launch of ENDURANCE Hip Solutions, a new system of instruments and devices that marks the company’s entry into the rapidly growing field of hip arthroscopy.

28 Sep 2012

U.S. Pharmacopeial announces winners of 2012-13 Global Fellowship awards

Since the program's inception more than thirty years ago, USP has invested nearly $4 million in over 200 fellowship awards.

28 Sep 2012

TRIL Centre announces Falls Awareness Day on Oct. 4

The TRIL Centre with Get Ireland Active announces Falls Awareness Day, Thursday 4th October 2012. One in three people over the age of 65 will fall every year in Ireland. Two-thirds of this group will fall again within six months, leading to risk of hospitalisation and significant health decline. As well as physical injuries suffered, the psychological and social consequences of falling can have a huge impact on the faller.

28 Sep 2012

Conditionally reprogrammed cells help identify effective therapy for HPV-positive RRP

Using a newly discovered cell technology, Georgetown University Medical Center researchers were able to identify an effective therapy for a patient with a rare type of lung tumor. The single case study, reported in the September 27 issue of New England Journal of Medicine, provides a snapshot of the new technology's promising potential; however, researchers strongly caution that it could be years before validation studies are completed and regulatory approval received for its broader use.

28 Sep 2012

Intellectual disability often results from genetic causes that are not inherited

New research published Online First in The Lancet suggests that a high proportion of severe intellectual disability results from genetic causes that are not inherited. These findings are good news for parents, indicating a low risk of passing on the disorder to further children.

28 Sep 2012

Inhibiting TRPV4 protects against diet-induced obesity, inflammation and insulin resistance

Ember Therapeutics, Inc., a company harnessing breakthroughs in brown fat biology and insulin sensitization to revolutionize the treatment of metabolic disease, today announced the publication of key preclinical data demonstrating that inhibition of the Transient Receptor Potential Vanilloid (TRPV) family of ion channels - specifically TRPV4 - resulted in activation of brown/beige fat and protection from diet-induced obesity, inflammation and insulin resistance. Ember holds an exclusive option to license these TRPV4 findings and technology.

28 Sep 2012

Molecular link between thermogenesis and development of inflammation in fat cells

Flipping a newly discovered molecular switch in white fat cells enabled mice to eat a high-calorie diet without becoming obese or developing the inflammation that causes insulin resistance, report scientists from Dana-Farber Cancer Institute.

28 Sep 2012

Boston Scientific receives CE MARK approval for Vercise DBS to treat Parkinson's

Boston Scientific Corporation received CE Mark approval for use of its Vercise Deep Brain Stimulation (DBS) System for the treatment of Parkinson's disease.

28 Sep 2012

Evidence does not support claims of Cogmed Working Memory Training

A target article in the Journal of Applied Research in Memory and Cognition concludes that evidence does not support the claims of Cogmed Working Memory Training. Additional experts weigh in with commentary papers in response.

28 Sep 2012

Janssen, Health 2.0 announce partnership

Today Janssen Healthcare Innovation (JHI), a team within Janssen Research & Development, LLC. (Janssen), announced the Janssen Connected Health Challenge Europe 2012 in partnership with Health 2.0.

28 Sep 2012

Private Healthcare Australia grants reimbursement code to IDEV’s SUPERA stent

IDEV Technologies, Inc. (IDEV), an emerging global innovator in peripheral devices, today announced that Private Healthcare Australia has granted the Company a reimbursement code for the SUPERA stent.

28 Sep 2012

Roundup: Md. Blues chief pans hospital costs shift plan; Pharmacies struggle with new drug controls

Negotiations to avert a breakdown in Maryland's unique system of regulating hospital prices have deteriorated into a stalemate between the state's largest insurer and the Maryland Hospital Association. CareFirst BlueCross BlueShield CEO Chet Burrell, speaking out for the first time about the talks, blames hospitals for their proposal to shift hundreds of millions in costs to CareFirst and other private insurers in an attempt to control rising Medicare spending.

28 Sep 2012